贛鋒鋰業(01772.HK)提高新型鋰電池項目產能建設規模
贛鋒鋰業(01772.HK)公布,董事會同意將年產15GWh的新型鋰電池項目,擴建為年產30GWh的新型鋰電池項目,包括在江西新余高新技術產業開發區投資不超過62億元人民幣建設動力電池年產10GWh新型鋰電池項目,以及在重慶兩江新區投資96億元人民幣建設重慶贛鋒鋰電科技有限公司年產20GWh新型鋰電池研發及生產基地項目。
另外,公司亦計劃由贛鋒鋰電以自有資金不超過35億元人民幣,投資建設年產6GWh新型鋰電池生產項目。而贛鋒鋰電子公司贛鋒新鋰源將以自有資金不超過20億元人民幣,投資建設年產20億隻小型聚合物鋰電池項目。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.